Navigation Links
BioTrends Announces the Continuation of a Syndicated Report Series: TreatmentTrends: CKD Stages 1-5ND
Date:3/13/2013

EXTON, Pa., March 13, 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for specialized biopharmaceutical issues, announces the continuation of the report series entitled TreatmentTrends: Chronic Kidney Disease Stages 1-5 Non-Dialysis. BioTrends plans to field the third wave of this research similarly to the two waves conducted in 2012, with each wave consisting of findings from a quantitative survey with 250 physicians (100 nephrologists, 100 primary care physicians, and 50 endocrinologists). Below are some key findings from the second wave of this report series; these items and others will be tracked in the third wave of research to observe changes over time:

  • The majority of physicians feel that patients are referred to nephrologists too late, nephrologists are significantly more likely than PCPs to feel this way
  • According to nephrologists, the primary reason that PCPs refer CKD patients to nephrologists is based on a high creatinine level or rising creatinine levels
  • For many medication classes, treatment tends to increase as CKD worsens - by Stage 5ND, approximately forty percent of patients are on phosphate binders, approximately forty percent are on oral active Vitamin D, and just over twenty percent are on erythropoiesis-stimulating agents
  • Similar to the first wave of research, physicians tend to report moderate to high interest in Concert Pharmaceutical's CTP-499 and Mitsubishi Tanabe's AST-120
  • (Logo:  http://photos.prnewswire.com/prnh/20130103/MM36805LOGO )


    SOURCE BioTrends Research Group
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related medicine technology :

    1. Keryx Biopharmaceuticals Announces Appointment of Amit Sharma, M.D. as Vice President, Medical Affairs
    2. Imprimis Pharmaceuticals Announces Underwriter Exercise of Over-Allotment Option
    3. PDI, Inc. Announces $17 Million Multi-Year Sales Contract
    4. BD Announces Appointment of Dr. Ellen Strahlman as Chief Medical Officer and Senior Vice President, Research & Development
    5. N30 Pharmaceuticals Announces First Patient Treated in Clinical Trial of N6022 in Cystic Fibrosis
    6. HeartWare International, Inc. Announces Pricing of Public Offering of Common Stock
    7. Johnson & Johnson Announces Opening of London Innovation Centre
    8. GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2012
    9. Jensen Dental Announces Launch of the Preciso Digital Dentistry Solution; Includes New CAD/CAM Software and Website
    10. MedShape, Inc. Announces New 10mm DynaNail
    11. I-Flow Announces Bus Tour to Educate Care Providers on Acute Surgical Pain Management
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/26/2015)... , May 26, 2015  PAREXEL International Corporation (NASDAQ: ... presenting at the Goldman Sachs Healthcare Conference in Palos ... Chief Executive Officer, will be making a presentation on ... on Tuesday, June 9, 2015. A live ... "Investors" section of PAREXEL,s website at www.PAREXEL.com ...
    (Date:5/26/2015)... 2015  Halyard Health, Inc. (NYSE: HYH ) today ... officer will present at the 2015 Morgan Stanley Leveraged Finance ... 8:45 a.m., CDT on Thursday, June 4. A ... Investors section of the Halyard Health website at https://halyardhealth.investorroom.com/ ... About Halyard Health: Halyard Health (NYSE: ...
    (Date:5/26/2015)... , May 26, 2015  BioSpecifics Technologies Corp. (NASDAQ: ... class collagenase-based products marketed as XIAFLEX ® in ... announced today that BioSpecifics, President, Tom Wegman , ... 2015 Healthcare Conference.    The presentation will ... p.m. ET in New York, NY ...
    Breaking Medicine Technology:PAREXEL International To Present At Goldman Sachs Healthcare Conference 2BioSpecifics Technologies Corp. to Present at the Jefferies 2015 Healthcare Conference 2
    ... MEETING, Pa., Nov. 8, 2010 Keeping radiation ... hospitals, particularly in computed tomography (CT), which has undergone some ... side is that CT delivers some of the highest radiation ... measures for delivering the appropriate radiation dose can result in ...
    ... Biotechnologies Corporation, a leader in the emerging field of ... financial support for the company,s lead oncology product, Rexin-G, ... Services (HHS), and the National Institutes of Health (NIH) ... latest support for the clinical advancement of Rexin-G comes ...
    Cached Medicine Technology:ECRI Institute Service to Address CT Radiation Dose Safety 2ECRI Institute Service to Address CT Radiation Dose Safety 3Epeius Biotechnologies Awarded Federal Grant Advancing Tumor-Targeted Cancer Therapy 2
    (Date:5/26/2015)... Mr. Larry Westenberg is a Licensed Clinical ... or NLP. Mr. Westenberg is recently also certified ... RRT®. While many people have learned small portions ... specific areas, Mr. Westenberg has been studying the application ... He works with people suffering the effects of ...
    (Date:5/26/2015)... May 26, 2015 Hexagon Geospatial is ... Defence and Space in a new content-sharing program that ... for use in the development of smart applications. ... this partnership combines optical satellite data from Airbus Defence ... tear down the walls between geospatial content, software and ...
    (Date:5/26/2015)... 26, 2015 Based on numerous suggestions ... undertaken a comprehensive upgrade of its purchasing page and ... To thank users for their feedback and support of ... trial transcription service promotion. , This promotion ... to June 9 this year. During this period, AnyTranscription ...
    (Date:5/26/2015)... San Antonio, TX (PRWEB) May 26, 2015 ... announce the opening of its newest clinic on May 25, ... found at 1919 Rogers Road, Suite 102 in Westover Hills ... late as 7 P.M. , “We’re thrilled about opening ... to reach more of our neighbors in San Antonio and ...
    (Date:5/26/2015)... Scientists at the University of Pennsylvania believe ... mesothelioma patients benefit from immunotherapy; surgery may be the ... the new research. Click here to read it ... surgery and pulmonology theorized that, because large mesothelioma tumors ... immunotherapy drugs might work better if the tumor size ...
    Breaking Medicine News(10 mins):Health News:Hexagon Geospatial and Airbus Defense Establish Partnership 2Health News:Hexagon Geospatial and Airbus Defense Establish Partnership 3Health News:Enjoy AnyTranscription’s First-class Audio/Video Transcription Service for Just $0.01 2Health News:Enjoy AnyTranscription’s First-class Audio/Video Transcription Service for Just $0.01 3Health News:TexPTS Announces New Clinic in San Antonio 2Health News:Researchers Say Surgery May Restore Effectiveness of Immunotherapy for Mesothelioma, According to Surviving Mesothelioma 2
    ... The air in some school classrooms may contain higher ... inhaled deep into the lungs than polluted outdoor ... an article in ACS, semi-monthly journal Environmental Science ... increasing concern in recent years over the health effects ...
    ... , , ATLANTA, Dec. 22 ... leader in automated revenue integrity solutions that improve healthcare providers, ... of first in the Revenue Cycle - Chargemaster Management market ... Software & Professional Services" report, published December 2009. KLAS is ...
    ... , , WASHINGTON, Dec. 22 ... Majority Leader Harry Reid and Senators Max Baucus (D-MT), Christopher ... Senate health bill, the Chairperson and President of the National ... President and CEO Rafael A. Fantauzzi: , "We are ...
    ... study authored by a UT Southwestern Medical Center researcher has ... than a placebo in several other applications previously thought to ... of drugs used to increase red blood cells in patients ... in a study of 4,038 patients, it did little to ...
    ... form of disease , TUESDAY, Dec. 22 (HealthDay News) -- ... may offer lifetime protection against the progression of the lung ... mice. , The most common form of emphysema in young ... the alpha-1 anti-trypsin gene, the authors of the study pointed ...
    ... CITY, Mo., Dec. 22 During this turbulent ... been immune to public scrutiny and fiscal pressures. The news ... insurance, creating skepticism and frustration for many policyholders who are ... their families. , As the new year approaches, the ...
    Cached Medicine News:Health News:Craneware's Chargemaster Toolkit(R) Earns #1 KLAS Rank for Fourth Consecutive Year 2Health News:Craneware's Chargemaster Toolkit(R) Earns #1 KLAS Rank for Fourth Consecutive Year 3Health News:National Puerto Rican Coalition Urges Passage of Senate Health Bill 2Health News:Anemia drug not helpful for kidney disease patients 2Health News:Gene Therapy Holds Promise for Emphysema 2Health News:After Tough 2009, Improved Accountability and Consistent Insurance Industry Standards Key in 2010 2Health News:After Tough 2009, Improved Accountability and Consistent Insurance Industry Standards Key in 2010 3Health News:After Tough 2009, Improved Accountability and Consistent Insurance Industry Standards Key in 2010 4
    ... the pre-analytical process is receiving increased interest ... Total Laboratory Automation (TLA) used to be ... only attractive for certain laboratories. In the ... emerged: A concept based on pre-analytical, analytical ...
    ... proven reliability, Sorvall offers the CW-2 ... washing and centrifugation system that offers ... for stat testing, easy-to-see digital readouts, ... procedures. High reliability, based on 40 ...
    ... be used as a manual cell washer, as ... AHG spins, or as a vacutainer style blood ... washing rotor: easy to see pellets, securely holds ... for vacutainers, glove friendly membrane panels, cover interlock ...
    ... High speed refrigerated floor-standing centrifuge. Powerful, ... reproducibility, informative display, display in 4 ... refrigeration, true sample temperature control, imbalance ... lid interlock, current and temperature limitation, ...
    Medicine Products: